INSY

Insys Therapeutics, Inc.
INSY

Overview Fund Activity
Delisted

INSY was delisted on the 18th of June, 2019.

Back to rankings

112 hedge funds and large institutions have $170M invested in Insys Therapeutics, Inc. in 2017 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 22 increasing their positions, 35 reducing their positions, and 25 closing their positions.

Holders
112
Holders Change
-4
Holders Change %
-3.45%
% of All Funds
2.54%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
22
Increased
22
Reduced
35
Closed
25
Calls
$4.87M
Puts
$3.66M
Net Calls
+$1.21M
Net Calls Change
+$3.24M

Top Buyers

1
Mirae Asset Global Investments
1
Mirae Asset Global Investments
South Korea
$14.2M
2
EMG
2
ETF Managers Group
New Jersey
$3.26M
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$24.4M
4
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$1.15M
5
PAM
5
Panagora Asset Management
Massachusetts
$2.05M

Top Sellers

1
O
1
OrbiMed
New York
$52M
2
Invesco
2
Invesco
Georgia
$187K
3
FHAM
3
Folger Hill Asset Management
New York
$0
4
SCM
4
Schneider Capital Management
Pennsylvania
$0
5
Balyasny Asset Management
5
Balyasny Asset Management
Illinois
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
ZIM
126
Zacks Investment Management
Illinois
– -$111K -12,525 Closed
SG Americas Securities
127
SG Americas Securities
New York
– -$101K -11,324 Closed
TRCT
128
Tower Research Capital (TRC)
New York
– -$32K -3,578 Closed
NFG
129
Next Financial Group
Texas
– -$3K -380 Closed
Toronto Dominion Bank
130
Toronto Dominion Bank
Ontario, Canada
– -$3K -363 Closed
HWP
131
Hefty Wealth Partners
Indiana
– -$3K -290 Closed
MIM
132
Macroview Investment Management
Maryland
– -$1K -100 Closed
2 3 4 5
6